Geetha Sadasivan Nair R, Narayanan Nair A, Sun S
RSC Adv. 2024; 14(43):31756-31767.
PMID: 39380648
PMC: 11459447.
DOI: 10.1039/d4ra05586a.
Pelliccia S, Russomanno P, Barone S, Mateu B, Alfano A, Miranda M
J Med Chem. 2024; 67(16):14256-14276.
PMID: 39115219
PMC: 11482282.
DOI: 10.1021/acs.jmedchem.4c01109.
Padua D, Figueira P, Pinto M, Maia A, Peixoto J, Lima R
Cancers (Basel). 2023; 15(17).
PMID: 37686684
PMC: 10487151.
DOI: 10.3390/cancers15174406.
Subbaiah K, Wu J, Tang W, Yao P
J Cardiovasc Dev Dis. 2023; 10(2).
PMID: 36826549
PMC: 9963048.
DOI: 10.3390/jcdd10020052.
Cho H, Kim K
Pharmaceutics. 2022; 14(3).
PMID: 35335928
PMC: 8950944.
DOI: 10.3390/pharmaceutics14030552.
Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials.
Sousa S, Feliciano J, Pita T, Soeiro C, Mendes B, Alves L
Antibiotics (Basel). 2021; 10(8).
PMID: 34438992
PMC: 8389044.
DOI: 10.3390/antibiotics10080942.
Protective Effect of Ciclopirox against Ovariectomy-Induced Bone Loss in Mice by Suppressing Osteoclast Formation and Function.
Ihn H, Lim J, Kim K, Nam S, Lim S, Lee S
Int J Mol Sci. 2021; 22(15).
PMID: 34361069
PMC: 8348120.
DOI: 10.3390/ijms22158299.
Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria.
Bernardo-Seisdedos G, Charco J, SanJuan I, Garcia-Martinez S, Urquiza P, Erana H
J Pers Med. 2021; 11(6).
PMID: 34071291
PMC: 8230281.
DOI: 10.3390/jpm11060485.
Ciclopirox Hydroxypropyl Chitosan (HPCH) Nail Lacquer: A Review of Its Use in Onychomycosis.
Piraccini B, Iorizzo M, Lencastre A, Nenoff P, Rigopoulos D
Dermatol Ther (Heidelb). 2020; 10(5):917-929.
PMID: 32705532
PMC: 7477053.
DOI: 10.1007/s13555-020-00420-9.
Synthesis and antitumor activity against HepG-2, PC-3, and HCT-116 cells of some naphthyridine and pyranopyridinecarbonitrile derivatives.
Mohamed S, Abdel-Hafez N, Amr A, Awad H
Russ J Gen Chem. 2020; 87(6):1264-1274.
PMID: 32288469
PMC: 7104393.
DOI: 10.1134/S1070363217060226.
Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.
Vikas A, Rashmin P, Mrunali P, Chavan R, Kaushik T
AAPS PharmSciTech. 2020; 21(2):67.
PMID: 31938980
DOI: 10.1208/s12249-019-1591-9.
Structures, Photoresponse Properties, and Biological Activity of Dicyano-Substituted 4-Aryl-2-pyridone Derivatives.
Mandal T, Pathak S, Dey A, Islam M, Seth S, Masum A
ACS Omega. 2019; 4(4):7200-7212.
PMID: 31459825
PMC: 6649035.
DOI: 10.1021/acsomega.9b00289.
Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs.
Weir S, Wood R, Schorno K, Brinker A, Ramamoorthy P, Heppert K
J Pharmacol Exp Ther. 2019; 370(2):148-159.
PMID: 31113837
PMC: 6614794.
DOI: 10.1124/jpet.119.257972.
Repositioning the Old Fungicide Ciclopirox for New Medical Uses.
Shen T, Huang S
Curr Pharm Des. 2016; 22(28):4443-50.
PMID: 27238364
PMC: 6623967.
DOI: 10.2174/1381612822666160530151209.
Chemical Constituents and an Alternative Medicinal Veterinary Herbal Soap Made from Senna macranthera.
Inoue Andrade F, Purgato G, Maia T, Siqueira R, Lima S, Diaz G
Evid Based Complement Alternat Med. 2015; 2015:217598.
PMID: 25821480
PMC: 4363604.
DOI: 10.1155/2015/217598.
Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.
Tabara K, Szewczyk A, Bienias W, Wojciechowska A, Pastuszka M, Oszukowska M
Postepy Dermatol Alergol. 2015; 32(1):40-5.
PMID: 25821426
PMC: 4360009.
DOI: 10.5114/pdia.2014.40968.
Easy access to Evans' oxazolidinones. Stereoselective synthesis and antibacterial activity of a new 2-oxazolidinone derivative.
Diaz G, de Freitas M, Ricci-Silva M, Diaz M
Molecules. 2014; 19(6):7429-39.
PMID: 24914892
PMC: 6270906.
DOI: 10.3390/molecules19067429.
Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use.
Danby C, Boikov D, Rautemaa-Richardson R, Sobel J
Antimicrob Agents Chemother. 2012; 56(3):1403-6.
PMID: 22232293
PMC: 3294902.
DOI: 10.1128/AAC.05025-11.
Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent.
Subissi A, Monti D, Togni G, Mailland F
Drugs. 2010; 70(16):2133-52.
PMID: 20964457
DOI: 10.2165/11538110-000000000-00000.
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
Hoque M, Hanauske-Abel H, Palumbo P, Saxena D, DAlliessi Gandolfi D, Park M
Retrovirology. 2009; 6:90.
PMID: 19825182
PMC: 2770518.
DOI: 10.1186/1742-4690-6-90.
